TOPIC
bharat biotech
Made In India Malaria vaccines: WHO recommends second vaccine R21/Matrix-M for use in African countries, SII to produce
ANI -
The vaccine was developed by the Jenner Institute at Oxford University and Serum Institute of India with support from the European and Developing Countries Clinical Trials Partnership (‘EDCTP’), the Wellcome Trust, and the European Investment Bank (‘EIB’).
World’s first malaria vaccine: GAVI to launch 18 million doses in 12 countries, know how India’s Bharat Biotech and Serum Institute are going to...
Gavi, the vaccine alliance, to provide 18 million doses of malaria vaccine to African countries. Bharat Biotech and Serum Institute of India are going to be the manufacturers in the global effort.
iNCOVACC can produce 3 immune responses, no other nasal vaccine in the world can produce: Bharat Biotech Chairman Dr Krishna Ella
ANI -
An initial manufacturing capacity of several million doses per annum has been established, this can be scaled up to a billion doses as required. iNCOVACC is priced at INR 325/dose for large volume procurement by State Governments and Govt of India, as per an official release.
Bharat Biotech launches the world’s first intranasal Covid vaccine iNCOVACC on Republic Day
ANI -
The firm said despite the relatively low demand for Covid vaccines, "Bharat Biotech continued product development in intranasal vaccines, to be well-prepared with platform technologies for future infectious diseases. Bharat Biotech has also initiated the development of variant-specific vaccines for COVID in an attempt to be future-ready".
‘Misleading and fallacious’: Govt refutes reports claiming that Covaxin approval was rushed due to political pressure, Bharat Biotech also denies
Govt of India and Bharat Biotech deny claims that approval for Covaxin was rushed and procedures were skipped
As Covid-19 vaccine precaution doses become available at private hospitals, Covishield and Covaxin prices cut to Rs 225
Serum Institute of India and Bharat Biotech reduce the price of Covishield and Covaxin vaccines to ₹225 per dose
Court orders The Wire to take down 14 articles against Bharat Biotech and Covaxin, not to publish any more defamatory reports
A court in Telangana has ordered The Wire to take down 14 articles it had published against Bharat Biotech
Studies suggest COVAXIN booster dose highly effective against Omicron and Delta variant: Details
Booster dose of COVAXIN is safe and may be necessary to ensure persistent immunity to prevent breakthrough infections.
‘Please be responsible’: Bharat Biotech ‘fact-checks’ TOI, Wire and others who have spread lies against Covaxin
Bharat Biotech has shared a list of media outlets who have spread false information against Covaxin in the last few days.
DCGI grants emergency use approval to Bharat Biotech’s Covaxin for minors aged 12 to 18
DCGI has granted emergency use approval for Bharat Biotech's Covaxin for people in the age group 12 years to 18 years.
